These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2685709)

  • 1. Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study.
    Packer AJ; McCuen BW; Hutton WL; Ramsay RC
    Ophthalmology; 1989 Oct; 96(10):1491-4. PubMed ID: 2685709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium hyaluronate (Healon) in closed vitrectomy.
    Folk JC; Packer AJ; Weingeist TA; Howcroft MJ
    Ophthalmic Surg; 1986 May; 17(5):299-306. PubMed ID: 3725301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
    Neely KA; Scroggs MW; McCuen BW
    Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic effects of air versus fluid in diabetic vitrectomy.
    Joondeph BC; Blankenship GW
    Ophthalmology; 1989 Dec; 96(12):1701-6; discussion 1706-7. PubMed ID: 2695874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of post-vitrectomy persistent vitreous hemorrhage in pseudophakic eyes.
    Landers MB; Perraki AD
    Am J Ophthalmol; 2003 Dec; 136(6):989-93. PubMed ID: 14644207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
    Jirawison C; Ittipunkul N
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
    Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
    Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous hemorrhage after vitrectomy for diabetic retinopathy.
    Novak MA; Rice TA; Michels RG; Auer C
    Ophthalmology; 1984 Dec; 91(12):1485-9. PubMed ID: 6521989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH; Chen MS
    Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Ferenchak K; Duval R; Cohen JA; MacCumber MW
    Retina; 2014 Jun; 34(6):1177-81. PubMed ID: 24457977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular human thrombin infusion in diabetic vitrectomies.
    Verdoorn C; Hendrikse F
    Ophthalmic Surg; 1989 Apr; 20(4):278-9. PubMed ID: 2733994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.
    Wu WC; Chang SM; Chen JY; Chang CW
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):363-71. PubMed ID: 11572467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Lee BJ; Yu HG
    Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
    Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraocular aspiration of sodium hyaluronate on postoperative intraocular pressure.
    Stamper RL; DiLoreto D; Schacknow P
    Ophthalmic Surg; 1990 Jul; 21(7):486-91. PubMed ID: 2204854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.